Published in
American Society for Clinical Investigation, Journal of Clinical Investigation, 20(131), 2021
DOI: 10.1172/jci145035
Links
Tools
Targeting enhancer reprogramming to mitigate MEK inhibitor resistance in preclinical models of advanced ovarian cancer
Journal article published in 2021 by
Shini Liu,
Qiong Zou,
Jie-Ping Chen,
Xiaosai Yao 
,
Peiyong Guan ,
Weiting Liang ,
Peng Deng,
Xiaowei Lai,
Jiaxin Yin,
Jinghong Chen,
Rui Chen,
Zhaoliang Yu,
Rong Xiao,
Yichen Sun,
Jing Han Hong
and other authors.
,
Peiyong Guan ,
Weiting Liang ,
Peng Deng,
Xiaowei Lai,
Jiaxin Yin,
Jinghong Chen,
Rui Chen,
Zhaoliang Yu,
Rong Xiao,
Yichen Sun,
Jing Han Hong
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Postprint:
archiving forbidden
Data provided by 